Shenzhen Celestial Pharmaceuticals Ltd.
Industry
- Pharmaceuticals
Latest on Shenzhen Celestial Pharmaceuticals Ltd.
For a Chinese domestically developed, first-in-class, topical non-steroidal treatment, and the first new drug for plaque psoriasis in 25 years, benvitimod - also known as tapinarof and WBI-1001 - enco
Covered by the National Reimbursement Drug List? Check! Priced to compete with formidable competitors? Check! Product awareness among specialists and physicians? Check! For a Chinese domestically-deve
Some 10 years after its founding, China- and US-based Connect Biopharma Holdings Ltd. is readying a major regulatory filing for its lead candidate, a novel anti-interleukin 4 receptor alpha antibody
In a bid to introduce more innovative therapies to the country, China granted more green lights to new drugs in 2020, despite the global pandemic and the devotion of considerable attention to fight th